Abstract
Objective: It was
aimed to retrospectively examine the clinical and survival results of patients
who were consulted with the hematology clinic due to hematological disorders
related to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).
Materials
and methods: In this study, the data of patients who were
hospitalized and consulted to the hematology clinic due to hematological
disorders related to COVID-19 infection diagnosed by radiological findings
and/or PCR results in the Ministry of Health Istanbul Training and Research
Hospital between April 1 2020 and May 21 2020, were evaluated, retrospectively.
Results: Of the 48 patients evaluated in the study, 25 (52%) were female and 29 (60%) were 60 years old and above. Leukocytosis in 5(10%) patients, leukopenia in 19 (39%) patients, and D-Dimer ≥2ng/mL and Ferritin ≥500ml/ng in 32(66%) patients were remarkable. D-Dimer was found to be ≥2ng/mL and Ferritin ≥500ml/ng in 9 out of 10 patients in intensive care. A total of seven (14%) patients died. Conclusion: Patients who are over the age of 60, and have lymphocyte count <1000μl/ml, D-Dimer value above 2ng/mL, and ferritin over 500ml/ng are more likely to need a follow-up in the intensive care. For this reason, vaccination of people over the age of 60, moreover, the high antibody response obtained with the vaccine seems to be the most important precaution that can be taken against this disease.
Read
More About This Article: https://crimsonpublishers.com/cjmi/fulltext/CJMI.000622.php
Read
More Crimson Publishers Google Scholar Article: https://scholar.google.com/citations?view_op=view_citation&hl=en&user=QyNqlXEAAAAJ&citation_for_view=QyNqlXEAAAAJ:qjMakFHDy7sC
